CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates

EarningsNeutral
AI Analysis

Summary

Foghorn Therapeutics reported Q2 2026 results with a net loss but exceeded revenue estimates.

Importance:2/10
Sentiment:
0.20
earningsQ2revenueloss
Related Companies

Read the original article

Published by yahoo_finance on August 6, 2026 1:50 PM

Read Original